December 17th, 2022With Chondrosarcoma Awareness Day: February 6, less than two months away, we want to share stories of our community / our family who provide us with inspiration. Some of our members lost their battle with Chondrosarcoma. Others are surviving,...

December 10th, 2022International Chondrosarcoma Awareness Day February 6, 2023 Wear A Yellow Ribbon / Wrist Band and Show Your Support for Chondrosarcoma Research and Clinical Trials As many of you are aware to honor my daughter who passed away from Grade 3...

November 28th, 2022

November 28th, 2022Inhibrx has initiated a phase 2 clinical trial to treat unresectable or metastatic conventional chondrosarcoma. The poster was presented at the Connective Tissue Oncology Society (CTOS) in Vancouver, Canada from November 16-19. The results of the...

November 23rd, 2022Inhibrx is recruiting for Chondrosarcoma patients to participate in their Phase 2 study of the medication. Presently there are 130 openings for the Phase 2 trial. Summary is listed below, for more...

October 25th, 2022Background Central conventional chondrosarcoma (CS) is the most common primary malignant bone tumour in adults. Anatomical location, histopathology, and grading are the current criteria for determining treatment [1, 2], although providing prognoses...

October 24th, 2022SAN DIEGO, Oct. 20, 2022 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be presenting at multiple upcoming...

October 21st, 2022Here are pictures from our event: Steppin' for A Cause held on October 15, at Allen Pond in Bowie, Maryland. We had 50 people participate in our 5k Walk / Run and raised $3,200 ($500 more than last year). Thank you to everyone for your...